How an anticoagulant reversal agent is changing the treatment conversation

Sponsored by Boehringer Ingelheim Pty Ltd

The availability of an anticoagulant reversal agent in Australia has changed the conversation about treatment choices for patients and removed a concern for clinicians, a cardiologist says. Speaking to the limbic following a breakfast symposium, held at the recent Cardiology Society of Australia and New Zealand annual conference in Adelaide, Professor John Amerena a cardiologist ...

Already a member?

Login to keep reading.

© 2021 the limbic